- Details

Actos Bladder Cancer Lawyer
- Details
- Parent Category: Lawsuit News Alerts
- Category: Side Effects Lawsuit
Actos Bladder Cancer Lawyer
Actos Bladder Cancer Side Effects

Bladder cancer risk in patients using diabetes drug Actos dominated drug injury headlines in the United States and Europe for the last half of 2011. The top-selling diabetes drug with 60 percent of market share and $4.8 billion earning in 2010 was the number one choice of diabetics since 2007 following detection of cardiovascular risks linked to GlaxoSmithKline’s Avandia and consequent side effect lawsuits. Takeda Pharmaceuticals, the manufacturer of Actos, continues to claim that the drug helps reduce progression to Type 2 diabetes by 72%.
The recent discovery of Actos bladder cancer side effects risk, however, has raised safety concerns associated with the drug, and patients using the drug have flooded US courts, to file Actos related bladder cancer lawsuits. A report in Bloomberg has estimated that the total number of Actos side effect lawsuits could reach 10,000. On December 30, 2011, the Federal Judicial Panel on Multi District Litigation selected the Louisiana Western District federal court in Lafayette for consolidation of all Actos bladder cancer lawsuits.
Actos Bladder Cancer Side Effects Complaints
Actos is a class of drug known as thiazolidinediones and known as pioglitazone. Attorneys working with doihavealawsuit.com have stated that
On June 9, 2011, the French Agency for the Safety of Health Products instructed Takeda to recall Actos following the discovery of comparatively higher bladder cancer risk in diabetes patients who took the drug. Next day, Germany’s Federal Institute for Drugs and Medical Devices suspended the sale of the Actos nationwide pending the conclusion of investigations into Actos bladder side effects and tumor dangers. On June 15th, the FDA warned consumers and doctors about the potential bladder cancer risk linked to Actos. It formally updated labels and added black box warning to the drug on August 5, 2011, informing patients about the risk.
Do i Have A Lawsuit Attorneys Investigate
Actos Bladder Cancer lawyer filed a class action lawsuit filed in Louisiana in September 2011 claims that manufacturer Takeda was aware of Actos bladder cancer side effects after a cancer study in 2005 resulted in the discovery of drug induced tumors in rats. However, the safety information was withheld by Takeda.
Actos Bladder Cancer Research Studies
-
US FDA Report on Actos Bladder Cancer Risk
The federal regulator added black box warnings to Actos for bladder cancer side effects in June 2011, though it stopped short of recalling the drug pending further investigation. The FDA came to know about the Actos bladder cancer risk in September 2010 after mid-term report of a study sponsored by Takeda pointed to such a possibility. The drug safety study planned over 10 years concluded that the use of Actos for more than 24 months puts diabetes patients at a statistically higher risk of bladder cancer. The FDA has been conducting a comprehensive safety review of the drug since then. Its order on label change is viewed as an endorsement of the findings linking Actos to enhanced bladder tumor risk.
In May 2011, a meta-analysis report also highlighted "disproportionate bladder cancer risk” in diabetics taking Actos for a long time. The survey based on half million complaints against different diabetes medications received by the FDA adverse event reporting system highlighted that one-fifth of diabetics with bladder cancer were using Actos.
European MedicalAgency Study on Actos Bladder Cancer Risk
The European Medical Agency has also found a relatively higher risk of bladder cancer in Actos users. It used a public health alert in July 2011 cautioning doctors against prescribing the drug to patients with potential bladder tumor risk following a four-month safety review of the drug. The report of the study carried by EMA’s Committee for Medicinal Products for Human Use between March and June 2011 called for mandatory monitoring of patients during the first three to six months of Actos use. It advised doctors to follow patient selection and exclusion process before prescribing the drug to reduce Actos bladder cancer risk. The EMA also called for a pan-European epidemiological study on the risk of the drug among different age groups.
Actos bladder cancer risk came to limelight following the decision by French national drug regulator to disallow the marketing of the drug. A clinical study commissioned by the French National Health Insurance first publicly highlighted a close association between the drug and bladder tumor. It evaluated cancer risk in 155,000 diabetes patients prescribed Actos and other pioglitazone drugs between 2006 and 2009. A comparative analysis of the risk results with similar threat to 1.3 million diabetics using other drugs disclosed that Actos users were 22 percent more prone to bladder cancer than patients taking other medications. The report concluded that patients with cumulative pioglitazone dosage of 28,000 mg or above face significant cancer risk.
Hip Replacement Recall Class Action Lawsuit
- Details
- Parent Category: Lawsuit News Alerts
- Category: Class Action Lawsuit Alerts And News Information
Hip Replacement Recall Class Action Lawsuit
Hip Replacement Class Action Lawsuit
In light of the Depuy ASR hip replacement class action lawsuits, we would like to remind the general public that Johnson and Johnson has in fact acknowledged that every single one of these Depuy hip implants are more likely than not to be defective and that even hip replacement patients without any symptoms should be tested for metal poisoning at the very least.
This fact alone is grounds for a lawsuit.
As with any hip replacement recall class action lawsuit, the Depuy ASR recall lawsuits will require those with the implant to file either as part of a hip implant class action lawsuit, or as an individual claimant represented by an attorney in your hip recall case.
As we have seen with other hip implant lawsuits, these cases will be handled VIA MDL or multi district litigation.
If you have not recieved your Depuy hip recall lawsuit package or for any questions about future Depuy hip replacement implant multi district litigation, please contact the lead attorney handling these cases for Do I Have A Lawsuit by using the submit my case form found at the top of this page or by clicking here.
If you have not received your DePuy hip recall lawsuit information packet please call the lead law firm directly at 1 (800) 748-7115 or click here to submit your case for immediate case review `
Depuy Hip Recall Replacement Lawsuit
- Details
- Parent Category: Lawsuit News Alerts
- Category: Recall Lawsuit
Depuy Hip Recall Replacement Lawsuit
Depuy Hip Class Action Lawsuit
While it is doubtful that we can answer all of your questions in the space of this webpage, we encourage you to call the lead firm directly at 1-800-748-7115 with any and all questions you have related to Depuy Lawsuits , Depuy Hip Recall , Depuy Hip Replacement Recall or any other hip implant recall lawsuit related question. The following Depuy lawsuit Q&A has been put together as a general guide to answer some of the most common questions you have asked us about the Depuy Class Action Lawsuit as well as individual hip implant recall lawsuit information.
Q. My husband has the recalled Depuy hip implant, but we do not understand what this is all about. Can you explain this to us in plain english and let us know what we need to do next to file a lawsuit?
A. Thank you for writing us in reference to your husband's Depuy hip implant lawsuit. The Depuy ASR hip implant lawsuits are a result of these orthopaedic hip devices being recalled due to their abnormally high failure rates and studies showing that these recalled hip implant devices have caused metal poisoning resulting in nerve damage and tissue death in the bodies of Depuy hip replacement implant patients. Thus type of poison can cause serious permanent damage to the implant patients tissue health or death of.
The Depuy ASR and the Depuy ASR XL have been ordered recalled globally, with instruction that every single Depuy hip implant patient be tested for metal poisoning.
To register and start the process of filing your husbands Depuy ASR hip replacement lawsuit, please call the lead law firm directly at 1-800-748-7115 or click the green submit my case button found at the top of this page or.by clicking here.
Q. Hello and thank you so much for fighting to have these dangerous hip implants recalled. I am an active housewife / soccer mom and I was told that these Depuy hip implants were the best option for my lifestyle I have already had to have revision surgery after my implant dislocated. I cannot afford to pay for any test or another revision surgery so my question is will Johnson and Johnson pay for my testing and surgery?
A. Thank you for writing and giving us permission to repost your question.
The sad reality is that without legal representation ( a lawyer ) Johnson and Johnson Depuy may try to short change Depuy hip implant recipients and force them to pay for their own surgeries, testing and follow-up care.
The lead attorney has extensive experience in this area of law and has already began the process of forcing Johnson and Johnson to not only pay for all testing and medical care related to the Depuy hips, but has also began to file lawsuits against Depuy for monetary compensation related to the recalled hip implants.
Q. I have not had any problems with my Depuy hip implant, am I still at risk?
A. Yes. Your implant cold be leaking met toxins into your body that will kill tissue. At the very least you must undergo metal poisoning testing to make sure the device is not killing your internal organs.
Regardless of wether or not you have had problems with this implant, you may still have a lawsuit against this orthopaedic hip implant device manufacturer.
If you have not already, please feel free to call the.lead firm directl or submit your case now by clicking here.
Actos Bladder Cancer Side Effects Lawsuit
- Details
- Parent Category: Lawsuit News Alerts
- Category: Side Effects Lawsuit
Actos Bladder Cancer Side Effects Lawsuit
Actos Bladder Cancer Lawsuit
According to a report in Bloomberg, Takeda Pharmaceuticals may face more than 10,000 Actos side effect lawsuit over allegations linking the drug to bladder cancer and a host of adverse reactions in users. Actos has been the top-selling diabetes drug since 2007 after GlaxoSmithKline’s Avandia, another popular diabetes drug, lost ground following a spate of lawsuit linking it to cardiovascular and other fatal side effects. However, a mid-term FDA study report published in September 2010 disclosed that diabetes patients taking the drug face greater threat of suffering from bladder cancer.
In June 2011, the federal regulator warned about the risk of bladder cancer in patients using Actos for more than 12 months. The FDA has been monitoring the safety concerns related to the drug since last September. The disclosures prompted immediate withdrawal of the drug in France and Germany while a four-month study by the European Medical Agency also confirmed the potential cancer risk associated with Actos.
A large number of research reports have shown that Actos, known by its generic name pioglitazone, has a number of side effects that outweigh its benefits in the long run.
Actos Bladder Cancer
On June 15, 2011, a public health alert by the FDA highlighted a link between bladder cancer in diabetes patients and Actos side effects. It warned about higher risk of cancer in patients using the drug regularly for more than 12 months. The regulator was aware of Actos cancer side effects as early as September 2010 after the mid-term report of its 10-year long commissioned safety study came out. The FDA has warned healthcare professionals against prescribing Actos to patients with prior record of bladder cancer.
A study commissioned by the French National Health Insurance Fund has also found heightened bladder cancer risk in 155,000 diabetes patients in France treated with Actos from 2006 to 2009. According to the report, the Actos users with cumulative dosage exceeding 28,000 mg face
Free Case Review
Lawsuit Cases Popular Today
Latest Lawsuit List ( Sample List )
- Medical Malpractice Lawsuit
- Discrimination Lawsuit
- Multaq Side Effects Lawsuit
- School Sexual Abuse Lawsuit
- Sexual Abuse Lawsuit
- Penn State Sandusky Child Molestation Abuse
- Nursing Home Abuse Neglect Lawsuit
- Head And Spinal Injuries Lawsuit
- Auto Accident Lawsuit
- Wrongful Death Lawsuit
- Personal Injury Lawsuit
- Duragesic Side Effect Lawsuit
- Ketek Side Effect Lawsuit
- Lioresal Side Effects Lawsuit
- Wright Hip Replacement Implant Recall Lawsuit
- Remicade Side Effect Lawsuit
- Tegretol Side Effects Lawsuit
- Cymbalta Side Effects Lawsuit
- Risperdal Side Effects Lawsuit
- Byetta Side Effects Lawsuit

